Ultragenyx Pharmaceutical Inc., Director at Arcturus Therapeutics, holds 1.40M shares in Arcturus Therapeutics (Ticker: ARCT). Most recently, Ultragenyx Pharmaceutical Inc. Sold $800,000 shares of Arcturus Therapeutics on Aug 12, 2021 for an estimated value of 43.63M.
Ultragenyx Pharmaceutical Inc. insider profile FAQ
What is the percentage of profitable transactions made by Ultragenyx Pharmaceutical Inc.?
The percentage of profitable transactions made by Ultragenyx Pharmaceutical Inc. is ―.
What is the average return per transaction made by Ultragenyx Pharmaceutical Inc.?
The average return per transaction made by Ultragenyx Pharmaceutical Inc. is ―.
What stocks does Ultragenyx Pharmaceutical Inc. hold?
Ultragenyx Pharmaceutical Inc. holds: ARCT stocks.
What was Ultragenyx Pharmaceutical Inc.’s latest transaction?
Ultragenyx Pharmaceutical Inc. latest transaction was an Informative Sell of $43.63M.
What was Ultragenyx Pharmaceutical Inc.'s most profitable transaction?
Ultragenyx Pharmaceutical Inc.’s most profitable transaction was an Informative Sell of ARCT stock on August 12, 2021. The return on the trade was 61.50%.
What is Ultragenyx Pharmaceutical Inc.'s role in Arcturus Therapeutics?
Ultragenyx Pharmaceutical Inc.'s role in Arcturus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.